Cargando…
Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by a progressive loss of neurons and cognitive functions. Therefore, early diagnosis of AD is critical. The development of practical and non-invasive diagnostic tests for AD remains, however, an unmet need. In the present proof-of-concept study we investigat...
Autores principales: | Kenny, Aidan, Jiménez-Mateos, Eva M., Zea-Sevilla, María Ascensión, Rábano, Alberto, Gili-Manzanaro, Pablo, Prehn, Jochen H. M., Henshall, David C., Ávila, Jesús, Engel, Tobias, Hernández, Félix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817868/ https://www.ncbi.nlm.nih.gov/pubmed/31659197 http://dx.doi.org/10.1038/s41598-019-51837-y |
Ejemplares similares
-
Elevated Plasma microRNA-206 Levels Predict Cognitive Decline and Progression to Dementia from Mild Cognitive Impairment
por: Kenny, Aidan, et al.
Publicado: (2019) -
MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s disease
por: Wijesinghe, Printha, et al.
Publicado: (2023) -
Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus
por: Raoof, Rana, et al.
Publicado: (2017) -
P2X7 Receptor-Dependent microRNA Expression Profile in the Brain Following Status Epilepticus in Mice
por: Conte, Giorgia, et al.
Publicado: (2020) -
Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus
por: Engel, T, et al.
Publicado: (2010)